ORAL PRAZIQUANTEL KINETICS IN NORMAL AND SCHISTOSOMA-HAEMATOBIUM-INFECTED SUBJECTS

被引：7

作者：

OFORIADJEI, D ^{[1
]}

ADJEPONYAMOAH, KK ^{[1
]}

LINDSTROM, B ^{[1
]}

机构：

[1] NATL BOARD HLTH & WELF,DEPT DRUGS,UPPSALA,SWEDEN

来源：

THERAPEUTIC DRUG MONITORING | 1988年 / 10卷 / 01期

关键词：

D O I：

10.1097/00007691-198801000-00008

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：45 / 49

页数：5

共 8 条

[1]

DAVIS A, 1981, ARZNEIMITTEL-FORSCH, V31-1, P568

[2] CLINICAL PHARMACOLOGY IN NORMAL VOLUNTEERS OF PRAZIQUANTEL, A NEW DRUG AGAINST SCHISTOSOMES AND CESTODES - EXAMPLE OF A COMPLEX STUDY COVERING BOTH TOLERANCE AND PHARMACOKINETICS [J].

LEOPOLD, G ;

UNGETHUM, W ;

GROLL, E ;

DIEKMANN, HW ;

NOWAK, H ;

WEGNER, DHG .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (04) :281-291

[3]

Patzschke K, 1979, Eur J Drug Metab Pharmacokinet, V4, P149

[4] TREATMENT WITH PRAZIQUANTEL IN A PATIENT WITH SCHISTOSOMIASIS AND CHRONIC-RENAL-FAILURE [J].

PEHRSON, PO ;

BENGTSSON, E ;

DIEKMANN, HW ;

GROLL, E .

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1983, 77 (05) :687-688

[5] SINGLE DOSE ORAL TREATMENT IN URINARY SCHISTOSOMIASIS - A DOUBLE-BLIND TRIAL [J].

PUGH, RNH ;

TEESDALE, CH .

BRITISH MEDICAL JOURNAL, 1983, 286 (6363) :429-432

[6]

PUTTER J, 1979, EUR J DRUG METAB PH, V3, P143

[7]

SCOTT D, 1982, B WORLD HEALTH ORGAN, V60, P89

[8] QUANTITATIVE-DETERMINATION OF PRAZIQUANTEL IN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

XIAO, SH ;

CATTO, BA ;

WEBSTER, LT .

JOURNAL OF CHROMATOGRAPHY, 1983, 275 (01) :127-132

← 1 →